Skip to main content
Deborah Borfitz on Muck Rack

Deborah Borfitz

  • Senior Science Writer, Cambridge Healthtech Institute
Connecticut, Nashville
As seen in: Bio-IT World, Friends of Cancer Research, Integrative Practitioner, Zephyrnet, Clinical Research News, Diagnostics World, RamaOnHealthcare
Professional communicator and content strategist with advanced knowledge of the healthcare industry and board-level nonprofit experience.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Deborah

Contact Deborah, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Coming Soon: One-time Treatment for Debilitating Genetic Condition

|
By Deborah Borfitz
| Clinical Research News Verified
By Deborah Borfitz July 15, 2026 | Patients with hereditary angioedema have reason to be optimistic that regulatory approval of a one-time, in vivo CRISPR gene-editing therapy for the sudden and severe swelling attacks associated with the rare genetic condition could come as early as next year, according to vascular medicine specialist Danny Cohn, M.D., Ph.D., head of the hereditary angioedema clinic at Amsterdam University Medical Center and a principal investigator on the HAELO study...
Open in Who Shared Issue with article?

Risk for Lung Cancer Written in the Blood

|
By Deborah Borfitz
| Diagnostics World Verified
By Deborah Borfitz July 9, 2026 | Researchers in London have identified a 14-protein blood signature predictive of lung cancer risk more than five years before a clinical diagnosis. If the proteomics panel makes its way to routine clinical practice, it could prove invaluable in flagging individuals likely to benefit from preventive screening, according to Tej Pandya, a clinical Ph.D. student at the Francis Crick Institute.
Open in Who Shared Issue with article?

AI Interprets 3D Eye Scans to Improve Diagnoses, Speed up Trials

|
By Deborah Borfitz
| Diagnostics World Verified
By Deborah Borfitz July 8, 2026 | Thanks to several key advances in deep learning architecture, optical coherence tomography (OCT)—one of the most obtained medical images in the world—can now be used to predict disease one patient at a time.
Open in Who Shared Issue with article?
See all 796 articles